GlassScriptPhysician profile
Crystal P Le
NPI 1447678941
$1,819.15
in general payments reported to CMS, 2019-2025
12 companies · $373 in 2025
The $373 reported for 2025 was less than what a typical Glaucoma Specialist provider received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.53 · 2020: $278 · 2021: $37.97 · 2022: $253 · 2023: $496 · 2024: $340 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,209.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $606.65 | 2021-2025 | Hydrus Microstent, Rocklatan, Clareon |
| Abbvie INC. | $349.17 | 2022-2025 | |
| Allergan, INC. | $268.53 | 2019-2020 | |
| Sight Sciences, INC. | $115.37 | 2020-2025 | Omni Surgical System, Sion Surgical Instrument |
| Thea Pharma INC. | $93.52 | 2023-2025 | Iyuzeh |
| Oyster Point Pharma, INC. | $93.30 | 2022-2023 | Tyrvaya |
| Bausch & Lomb Americas INC. | $71.21 | 2023 | Vyzulta |
| Sun Pharmaceutical Industries INC. | $66.56 | 2023-2025 | Cequa |
| Glaukos Corporation | $64.28 | 2023-2024 | Idose |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $46.62 | 2020-2021 | |
| Abbott Laboratories | $28.56 | 2025 | Perclose Prostyle |
| New World Medical,INC. | $15.38 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.